KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Repurchased
Ratios

Pacira BioSciences (PCRX) Shares Outstanding (2016 - 2023)

Historic Shares Outstanding for Pacira BioSciences (PCRX) over the last 15 years, with Q3 2023 value amounting to $46.4 million.

  • Pacira BioSciences' Shares Outstanding rose 122.75% to $46.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $46.4 million, marking a year-over-year increase of 122.75%. This contributed to the annual value of $45.9 million for FY2022, which is 266.91% up from last year.
  • As of Q3 2023, Pacira BioSciences' Shares Outstanding stood at $46.4 million, which was up 122.75% from $46.4 million recorded in Q2 2023.
  • In the past 5 years, Pacira BioSciences' Shares Outstanding ranged from a high of $46.4 million in Q3 2023 and a low of $41.3 million during Q1 2019
  • Moreover, its 5-year median value for Shares Outstanding was $44.4 million (2021), whereas its average is $44.1 million.
  • In the last 5 years, Pacira BioSciences' Shares Outstanding surged by 437.12% in 2021 and then skyrocketed by 122.75% in 2023.
  • Over the past 5 years, Pacira BioSciences' Shares Outstanding (Quarter) stood at $41.9 million in 2019, then increased by 4.13% to $43.6 million in 2020, then grew by 2.51% to $44.7 million in 2021, then grew by 2.67% to $45.9 million in 2022, then grew by 1.09% to $46.4 million in 2023.
  • Its Shares Outstanding was $46.4 million in Q3 2023, compared to $46.4 million in Q2 2023 and $46.0 million in Q1 2023.